Botfet / Company detail

NVO

universe

Novo Nordisk A/S

biotech

Moat score54out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic29.5%

Gross Margin81.0%

Revenue Cagr21.7%

Fcf Conversion28.3%

Fcf YieldNot available: currency mismatch

Interest Coverage37.3x

Market Cap B$172.5B

Pe9.9

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant54

Why it may endure

Moat breakdown

Quant: 54 · Curator: 0

Market Share Stability6

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener